2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Suspended
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
11
Venous Thromboembolism
10
Venous Thrombosis
4
Thrombosis
4
Treatment of Venous Thromboembolism in Cancer Patients
3
Pulmonary Embolism
3
Multiple Myeloma
3
Thromboembolism
2
Carcinoma, Non-Small-Cell Lung
2
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Respiratory Distress Syndrome
1
Pneumonia, Viral
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Motor Activity
1
Lymphoma
1
Liver Neoplasms
1
Liver Diseases
1
Leukemia
1
Hematologic Neoplasms
1
Genital Neoplasms, Female
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Embolism
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Interventions
siltuximab
4
tocilizumab
3
fludarabine
3
Cyclophosphamide
3
fludarabine phosphate
2
Interleukin 1 Receptor Antagonist Protein
2
AP 1903 reagent
2
talquetamab
1
otelixizumab
1
obinutuzumab
1
lopinavir-ritonavir drug combination
1
glofitamab
1
axicabtagene ciloleucel
1
Piperacillin, Tazobactam Drug Combination
1
Oxygen Inhalation Therapy
1
Oxaliplatin
1
Neuropsychological Tests
1
Metoprolol
1
Methylprednisolone
1
Magnetic Resonance Spectroscopy
1
Lopinavir
1
Leukapheresis
1
Infliximab
1
Hydroxychloroquine
1
Heparin, Low-Molecular-Weight
1
Gemcitabine
1
Gelsolin
1
Etanercept
1
Dexamethasone
1
Contrast Media
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cytokine Release Syndrome
×
Heparin, Low-Molecular-Weight
×
Clear all
NCT04394182
2022-03-29
ULTRA-COVID
Fundacion GenesisCare
Phase NA
Suspended
15 enrolled